BioStem Technologies acquires Bio-Tissue

David Najork · Founding Software Engineer

Published Apr 29, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$15M

Target

Bio-Tissue

Miami, Florida

Acquirer

BioStem Technologies

Asset/Business Division Sale

Status

Completed

BioStem Technologies agreed to acquire Bio-Tissue. Reported deal value: $15M. Status: Completed. Sector: MedTech. Target headquarters context: Miami, Florida, United States.

This page summarizes publicly available information about the transaction as of 2026-01-22. Figures and status may change as filings and press coverage update.

, a leading MedTech company focused on the development, manufacturing , and commercialization of placental-derived products for advanced wound care , today announced the closing of a definitive asset purchase agreement with BioTissue Holdings Inc , a pioneer and leader in regenerative healing, whereby BioStem acquired the BioTissue surgical and wound care business

Deal timeline

Announced

Jan 22, 2026 · biospace.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in MedTech with a reported deal value of $15M. Figures and status may change as sources update.

Sources: biospace.com · Primary article · FireStrike proprietary index